INFARINATO ROBERT M. (VP, Chief Financial Officer) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/15/2024ACC: 0001683168-24-005773
Officer· VP, Chief Financial Officer
Since Aug 2024
+8K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
+8K
Price / share
—
Trade value
—
% of position
New position
8/13/2024
0.00→8K
Total
Net shares
+8K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 8/13/2024 | A · Award | +8K | — | — | New position | 0.00 | 8K |
| Total | +8K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported